We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

193 hedge funds and large institutions have $679M invested in SANGAMO THERAPEUTICS INC in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 65 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $10M | Put options by funds: $7.84M

9% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 23

9% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 65

1.18% less ownership

Funds ownership: 52.97%51.79% (-1.2%)

2% less funds holding

Funds holding: 197193 (-4)

25% less capital invested

Capital invested by funds: $911M → $679M (-$232M)

Holders
193
Holders Change
-4
Holders Change %
-2.03%
% of All Funds
3.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
59
Reduced
65
Closed
23
Calls
$10M
Puts
$7.84M
Net Calls
+$2.2M
Net Calls Change
-$3.66M
Name Holding Trade Value Shares
Change
Change in
Stake
Hudson Bay Capital Management
26
Hudson Bay Capital Management
Connecticut
$4.28M +$247K +25,000 +6%
Bank of America
27
Bank of America
North Carolina
$4.12M +$982K +99,374 +28%
Two Sigma Investments
28
Two Sigma Investments
New York
$3.95M -$976K -98,757 -18%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$3.93M +$309K +31,274 +8%
Macquarie Group
30
Macquarie Group
Australia
$3.62M
Citadel Advisors
31
Citadel Advisors
Florida
$3.55M -$3.91M -395,059 -50%
Mirae Asset Global Investments
32
Mirae Asset Global Investments
South Korea
$3.24M +$559K +56,576 +19%
GIM
33
Granahan Investment Management
Massachusetts
$3.14M +$1.16M +117,129 +51%
Fidelity Investments
34
Fidelity Investments
Massachusetts
$2.74M -$557K -56,378 -16%
Connor, Clark & Lunn Investment Management (CC&L)
35
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.61M +$1.04M +105,116 +57%
UBS Group
36
UBS Group
Switzerland
$2.61M +$1.73M +174,571 +151%
Swiss National Bank
37
Swiss National Bank
Switzerland
$2.43M +$17.8K +1,800 +0.7%
Group One Trading
38
Group One Trading
Illinois
$2.22M +$756K +76,504 +45%
RJFSA
39
Raymond James Financial Services Advisors
Florida
$2.1M -$184K -18,628 -7%
Citigroup
40
Citigroup
New York
$2.08M -$2.15M -217,439 -49%
MIG
41
McGuire Investment Group
Rhode Island
$2.06M -$167K -16,908 -7%
PIM
42
Platinum Investment Management
Australia
$1.97M
AGA
43
Altrinsic Global Advisors
Connecticut
$1.95M
PP
44
PDT Partners
New York
$1.9M -$370K -37,388 -15%
B
45
Bailard
California
$1.8M -$782K -79,100 -28%
Millennium Management
46
Millennium Management
New York
$1.8M +$413K +41,768 +26%
Rafferty Asset Management
47
Rafferty Asset Management
New York
$1.79M -$97.7K -9,881 -5%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$1.76M +$300K +30,339 +18%
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$1.7M -$1.09M -109,954 -38%
AA
50
ALPS Advisors
Colorado
$1.6M -$113K -11,385 -6%

SGMO Hedge Fund Activity: Q3 2021 in Review

193 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2021, worth a combined $679M — down 25% from $911M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SGMO and 21 opened new positions — a net loss of 2 holders — while 65 trimmed existing stakes and 59 added.

The largest buyer was BlackRock, adding an estimated $14.9M. The largest seller was JP Morgan Chase, cutting an estimated $12.4M.

  • 193 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2021, down from 197 in Q2 2021.
  • Funds reported $679M of SANGAMO THERAPEUTICS INC stock for Q3 2021, down 25% quarter-over-quarter.
  • 21 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2021 and 23 closed out, a net change of -2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2021 was BlackRock, an estimated $14.9M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2021 was JP Morgan Chase, an estimated $12.4M sold.

Based on aggregated 13F filings for Q3 2021.